Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThungela Resources Regulatory News (TGA)

Share Price Information for Thungela Resources (TGA)

Share Price is delayed by 15 minutes
Get Live Data
707.00    27.00 (3.97%)
Bid:
704.00
Ask:
709.00
Spread: 5.00 (0.71%)
Market Cap: £899.90m
TGA Live PriceLast checked at - London Stock Exchange

Intraday Thungela Resources Share Chart

Trading Statement

28 Feb 2025 08:00

RNS Number : 8678Y
Thungela Resources Limited
28 February 2025
 

THUNGELA RESOURCES LIMITED

(Incorporated in the Republic of South Africa)

Registration number: 2021/303811/06

JSE Share Code: TGA

LSE Share Code: TGA

ISIN: ZAE000296554

Tax number: 9111917259

('Thungela' or the 'Company' and, together with its affiliates, the 'Group')

 

Thungela Resources Limited Trading Statement for the year ended 31 December 2024

 

Shareholders are advised that Thungela and its directors have a reasonable degree of certainty related to the expected financial results of the Group for the year ended 31 December 2024 in line with paragraph 3.4(b) of the JSE Listings Requirements. 

 

Expected earnings per share and headline earnings per share

 

Shareholders are advised that earnings per share ('EPS') for the year ended 31 December 2024 (the 'current period') is expected to be between R25.00 and R27.50, a decrease of between R10.16 and R12.66 per share compared to EPS of R37.66 for the year ended 31 December 2023 (the 'prior period'). Earnings attributable to the shareholders of the Group for the current period is expected to be between R3.4 billion and R3.7 billion.

 

Headline earnings per share1 ('HEPS') for the current period is expected to be between R24.00 and R26.50, a decrease of between R8.47 and R10.97 per share compared to HEPS of R34.97 for the prior period. Headline earnings attributable to the shareholders of the Group for the current period is expected to be between R3.2 billion and R3.5 billion.

 

These EPS and HEPS figures are calculated using a weighted average number of shares of 134,238,447 for the current period and 137,056,628 for the prior period.

 

The expected EPS and HEPS ranges for the current period are summarised in the table below:

 

Expected EPS/HEPS range (Rand per share)

Expected decrease from prior period

(Rand per share)

Expected decrease from prior period

(%)

EPS

25.00 - 27.50

10.16 - 12.66

27 - 34

HEPS

24.00 - 26.50

8.47 - 10.97

24 - 31

 

Key areas of judgement which may impact the expected EPS and HEPS figures above are in the process of being finalised, and any changes to these ranges, if necessary, will be communicated to shareholders. 

 

Thungela expects to release its financial results for the year ended 31 December 2024 on 17 March 2025. The financial results will be released on the Stock Exchange News Service of the JSE and the Regulatory News Service of the London Stock Exchange, and will be accompanied by an investor webinar and conference call on the same date.

 

The live webinar and conference call will start at 12:00 SAST (10:00 GMT). Details to register for the webinar and conference call are available below:

 

Webinar: https://78449.themediaframe.com/links/thungela250317_1200.html

 

Conference call: https://services.choruscall.za.com/DiamondPassRegistration/register?confirmationNumber=4371045&linkSecurityString=120f2faaf5

 

 

Deon Smith 

Chief financial officer

 

 

Footnote

1. HEPS is determined in reference to Circular 1/2023 - Headline earnings ('Circular 1/2023') as issued by the South African Institute of Chartered Accountants. In order to calculate headline earnings, earnings attributable to the equity shareholders of the Group is adjusted for separately identifiable remeasurements, as defined in Circular 1/2023, net of related tax and non-controlling interests.

 

 

Johannesburg

28 February 2025

 

Review of Trading Statement

The information contained in this Trading Statement is the responsibility of the directors of Thungela and has not been reviewed or reported on by the Group's independent external auditor. 

 

Disclaimer

This document includes forward-looking statements. All statements other than statements of historical facts included in this document, including, without limitation, those regarding Thungela's financial position, business, acquisition and divestment strategy, dividend policy, plans and objectives of management for future operations (including development plans and objectives relating to Thungela's products, production forecasts and reserve and resource positions), are forward-looking statements. By their nature, such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Thungela, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The Group assumes no responsibility to update forward-looking statements in this announcement except as required by law.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the market abuse regulation (EU) no. 596/2014 as amended by the market abuse (amendment) (UK mar) regulations 2019. Upon the publication of this announcement via the regulatory information service, this inside information is now considered to be in the public domain.

 

 

 

Investor Relations 

Hugo Nunes

Email: hugo.nunes@thungela.com

 

Shreshini Singh

Email: shreshini.singh@thungela.com

 

Media

Hulisani Rasivhaga

Email: hulisani.rasivhaga@thungela.com

 

UK Financial adviser and corporate broker

Panmure Liberum Limited

 

 

Sponsor

Rand Merchant Bank

(A division of FirstRand Bank Limited)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDVLBLELLXBBL
Date   Source Headline
23rd Dec 20242:00 pmRNSACQUISITION OF 15% INTEREST IN THE ENSHAM BUSINESS
10th Dec 20247:00 amRNSCFO Pre-close statement
4th Dec 20242:30 pmRNSDealings in Securities
3rd Dec 202412:00 pmRNSNotification of Treasury Shares
3rd Dec 202412:00 pmRNSDealings in securities
27th Nov 20241:00 pmRNSDealings in securities
25th Nov 202412:00 pmRNSDealings in securities
21st Nov 20242:00 pmRNSDealings in securities
20th Nov 20248:20 amRNSDEALINGS IN SECURITIES
11th Nov 20247:00 amRNSDEALINGS IN SECURITIES
4th Nov 20243:00 pmRNSCONFIRMATION OF TREASURY SHARES HELD
4th Nov 20241:00 pmRNSDEALINGS IN SECURITIES BY THE COMPANY SECRETARY
31st Oct 20242:00 pmRNSDealings in securities
25th Oct 20244:00 pmRNSNotification of Major Holdings
21st Oct 20242:00 pmRNSDEALING IN SECURITIES BY A PRESCRIBED OFFICER
18th Oct 20241:00 pmRNSDEALING IN SECURITIES BY A PRESCRIBED OFFICER
16th Oct 20242:00 pmRNSNotification of Major Holdings
4th Oct 20243:00 pmRNSDealings in securities
2nd Oct 20249:00 amRNSCONFIRMATION OF TREASURY SHARES HELD
26th Sep 20243:30 pmRNSAppointment Of Non-Executive Director
23rd Sep 20243:00 pmRNSDEALING IN SECURITIES BY A PRESCRIBED OFFICER
19th Aug 20243:00 pmRNSAppointment of Company Secretary
19th Aug 20247:01 amRNSDividend Declaration
19th Aug 20247:00 amRNSInterim Results
30th Jul 20243:00 pmRNSTR-1: Notification of Major Holdings
26th Jul 20243:00 pmRNSTransaction in Own Shares
2nd Jul 20243:00 pmRNSConfirmation of Treasury Shares Held
18th Jun 20248:00 amRNSPre-close and trading statement
11th Jun 202411:00 amRNSBoard Update
5th Jun 20242:00 pmRNSReport of proceedings at the AGM
5th Jun 202411:00 amRNSDirector/PDMR Shareholding
3rd Jun 20244:30 pmRNSCONFIRMATION OF TREASURY SHARES HELD
3rd Jun 20248:00 amRNSDealings in Securities
10th May 20248:00 amRNSDirector/PDMR Shareholding
3rd May 202412:00 pmRNSTotal Voting Rights
2nd May 202411:00 amRNSPassing away of Non-Executive Director
30th Apr 20248:00 amRNSNotice of AGM
29th Apr 202411:00 amRNSDealings in Securities
24th Apr 20248:00 amRNSPublication of Annual Reports
24th Apr 20248:00 amRNSAnnual Report
17th Apr 20241:00 pmRNSDealings in Securities
5th Apr 202410:00 amRNSConfirmation of Treasury Shares Held
4th Apr 20242:00 pmRNSDealings in Securities
4th Apr 202412:00 pmRNSDealings in Securities
28th Mar 20248:00 amRNSBEE Compliance Report
20th Mar 202411:00 amRNSDealing in Securities
18th Mar 20247:01 amRNSDividend Declaration
18th Mar 20247:00 amRNSResults Announcement
23rd Feb 20247:00 amRNSTrading Statement
9th Feb 20242:00 pmRNSDisclosure of Significant Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.